Month: April 2020
April 28, 2020 Targeting vascular KATP channel activity in Alzheimer’s disease Takeaway: Sulfonylurea drugs used to treat diabetes seem to inhibit the accumulation of Aβ by restoring vascular…
Alzheimer’s Afternoon Seminar Series APP and Bioenergetics Dr. Heather Wilkins, University of Kansas Medical Center April 23, 2020 Dr. Wilkins began by reviewing the “Amlyoid Cascade” and the…
Enhanced skeletal muscle as a novel determinant of CNS aging and Alzheimer’s disease Alzheimer’s Afternoons Seminar Series (April 21) Dr. Constanza J. Cortes, Brain Aging Physiology Lab, University…
Cholesterol and matrisome networks in Alzheimer’s disease Alzheimer’s Afternoons Seminar Series (April 16) Dr. Julia TCW is an Instructor at the Icahn School of Medicine at Mount Sinai…
Alzheimer’s disease and epilepsy: what can we learn from their similarities? Alzheimer’s Afternoons Seminar Series (April 14) Dr. Misha Zilberter, a staff research scientist from the Gladstone Institutes…
Cholesterol, Apoe4, and Alzheimer’s disease Alzheimer’s Afternoons Seminar Series (April 2) This seminar was presented by Dr. Rik van der Kant, a Research Associate in both the Faculty…
Alzheimer’s Disease: next generation mouse models Alzheimer’s Afternoons Seminar Series (March 31) Gareth Howell This seminar was presented by Dr. Gareth Howell, Associate Professor and the Diana Davis…
Alzheimer’s Disease: Tipping the energy balance Alzheimer’s Afternoons Seminar Series (March 26) Lance Johnson The Alzheimer’s Afternoons Seminar Series started off with a seminar by Dr. Lance Johnson…